11 research outputs found

    Machine Learning to Generate Adjustable Dose Distributions in Head-and-Neck Cancer Radiation Therapy

    Full text link
    In this work, we propose a Machine Learning model that generates an adjustable 3D dose distribution for external beam radiation therapy for head-and-neck cancer treatments. In contrast to existing Machine Learning methods that provide a single model, we create pairs of models for each organ-at-risk, namely lower-extreme and upper-extreme models. These model pairs for an organ-at-risk propose doses that give lower and higher doses to that organ-at-risk, while also encapsulating the dose trade-off to other organs-at-risk. By weighting and combining the model pairs for all organs-at-risk, we are able to dynamically create adjustable dose distributions that can be used, in real-time, to move doses between organs-at-risk, thereby customizing the dose distribution to the needs of a particular patient. We leverage a key observation that the training data set inherently contains the clinical trade-offs. We show that the adjustable distributions are able to provide reasonable clinical dose latitude in the trade-off of doses between organs-at-risk

    Decoding Clinical Biomarker Space of COVID-19: Exploring Matrix Factorization-based Feature Selection Methods

    Full text link
    One of the most critical challenges in managing complex diseases like COVID-19 is to establish an intelligent triage system that can optimize the clinical decision-making at the time of a global pandemic. The clinical presentation and patients’ characteristics are usually utilized to identify those patients who need more critical care. However, the clinical evidence shows an unmet need to determine more accurate and optimal clinical biomarkers to triage patients under a condition like the COVID-19 crisis. Here we have presented a machine learning approach to find a group of clinical indicators from the blood tests of a set of COVID-19 patients that are predictive of poor prognosis and morbidity. Our approach consists of two interconnected schemes: Feature Selection and Prognosis Classification. The former is based on different Matrix Factorization (MF)-based methods, and the latter is performed using Random Forest algorithm. Our model reveals that Arterial Blood Gas (ABG) O2 Saturation and C-Reactive Protein (CRP) are the most important clinical biomarkers determining the poor prognosis in these patients. Our approach paves the path of building quantitative and optimized clinical management systems for COVID-19 and similar diseases

    Distributed nonconvex optimization: Algorithms and convergence analysis

    No full text
    This thesis addresses the problem of distributed optimization and learning over multi-agent networks. Our main focus is to design efficient algorithms for a class of nonconvex problems, defined over networks in which each agent/node only has partial knowledge about the entire problem. Multi-agent nonconvex optimization has gained much attention recently due to its wide applications in big data analysis, sensor networks, signal processing, multi-agent network, resource allocation, communication networks, just to name a few. In this work, we develop a general class of primal-dual algorithms for distributed optimization problems in challenging setups, such as nonconvexity in loss functions, nonsmooth regularizations, and coupling constraints. Further, we consider different setup where each agent can only access the zeroth-order information (i.e., the functional values) of its local functions. Rigorous convergence and rate of convergence analysis is provided for the proposed algorithms. Our work represents one of the first attempts to address nonconvex optimization and learning over networks.</p

    ZONE: Zeroth-Order Nonconvex Multiagent Optimization Over Networks

    No full text

    NESTT: A Nonconvex Primal-Dual Splitting Method for Distributed and Stochastic Optimization

    Get PDF
    We study a stochastic and distributed algorithm for nonconvex problems whose objective consists a sum N/ nonconvex Li/N/ smooth functions, plus a nonsmooth regularizer. The proposed NonconvEx primal-dual SpliTTing (NESTT) algorithm splits the problem into N/ subproblems, and utilizes an augmented Lagrangian based primal-dual scheme to solve it in a distributed and stochastic manner. With a special non-uniform sampling, a version of NESTT achieves e-1 stationary solution using...gradient evaluations, which can be up to O(N)/ times better than the (proximal) gradient descent methods. It also achieves Q-linear convergence rate for nonconvex l1 penalized quadratic problems with polyhedral constraints. Further, we reveal a fundamental connection between {\it primal-dual} based methods and a few {\it primal only} methods such as IAG/SAG/SAGA.This is a proceeding from the 30th Conference on Neural Information Processing Systems (2016). Posted with permission.</p

    Decoding clinical biomarker space of COVID-19: Exploring matrix factorization-based feature selection methods

    No full text
    One of the most critical challenges in managing complex diseases like COVID-19 is to establish an intelligent triage system that can optimize the clinical decision-making at the time of a global pandemic. The clinical presentation and patients’ characteristics are usually utilized to identify those patients who need more critical care. However, the clinical evidence shows an unmet need to determine more accurate and optimal clinical biomarkers to triage patients under a condition like the COVID-19 crisis. Here we have presented a machine learning approach to find a group of clinical indicators from the blood tests of a set of COVID-19 patients that are predictive of poor prognosis and morbidity. Our approach consists of two interconnected schemes: Feature Selection and Prognosis Classification. The former is based on different Matrix Factorization (MF)-based methods, and the latter is performed using Random Forest algorithm. Our model reveals that Arterial Blood Gas (ABG) O2 Saturation and C-Reactive Protein (CRP) are the most important clinical biomarkers determining the poor prognosis in these patients. Our approach paves the path of building quantitative and optimized clinical management systems for COVID-19 and similar diseases.</p
    corecore